Short and Ultra-short-pulse ND: YAG 1064nm Lasers (Omer Smart and Omer Premium) for Stasis Dermatitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorScience Valley Research Institute

About this trial

This study tests two types of lasers (ND YAG 1064 short and ultra-short pulses) to treat hyperchromic skin lesions secondary to venous hypertension (stasis dermatitis)

Eligibility criteria

Qualifiers

Women or men aged 18 to 89 years with stasis dermatitis secondary to venous hypertension

Agreement with the terms of the survey and signing of the informed consent form

Availability to make the necessary appointments for treatment and follow-up

Provide consent to avoid pregnancy during treatment

Disqualifiers

Men and women with CEAP 2 to 6, low mobility, no stasis dermatitis.

Peripheral arterial disease.

History of known allergy to the drugs used in this study

Presence of other types of dermatitis in the lower extremities, such as allergic stasis eczema.

Trial design

Treatments tested in this trial

  • short-pulse ND: YAG 1064 laser
  • ultra-short-pulse ND: YAG 1064 laser
  • cold cream

Treatment groups

20 Participants
are divided into 3 treatment groups